Litter was collected from four turkey farms (eight houses) with a history o
f fluoroquinolone (FQ) treatment failure, 10 adult broiler breeder chicken
farms (43 houses) with one having a history of FQ treatment, and 30 broiler
chicken farms (110 houses) with 24 having a history of FQ treatment. In th
e turkey litter, the percentage of nalidixic acid-resistant tar 100 mug/ml)
coliforms/total number of coliforms ranged from 0.6% to 61.9%. Two of the
four farms had houses containing coliforms resistant to the two FQs, enrofl
oxacin (1 mug/ml) and sarafloxacin (1 mug/ml). There was also multiple resi
stance to other antimicrobials on all four turkey farms (ampicillin, tetrac
ycline, chloramphenicol, kanamycin). The level of total coliforms from the
adult broiler breeder litter was low, and there were no nalidixic acid-resi
stant isolates from any of the 10 farms. In the broiler chickens, 7 of 91 h
ouses with a history of FQ usage contained coliforms resistant to nalidixic
acid; however, 2 of the 19 houses on farms with no history of FQ usage had
nalidixic acid-resistant coliforms. All of the broiler farms with nalidixi
c acid-resistant isolates were also resistant to the FQ sarafloxacin, where
as only 3 of the 24 treatment history farms and 1 of the no-treatment histo
ry farms exhibited enrofluxacin-resistant coliforms in the litter.